{{Rsnum
|rsid=4886670
|Chromosome=15
|position=75157333
|Orientation=plus
|GMAF=0.3448
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 69.9 | 28.3 | 1.8
| HCB | 48.5 | 43.4 | 8.1
| JPT | 54.9 | 40.7 | 4.4
| YRI | 5.5 | 34.2 | 60.3
| ASW | 7.0 | 38.6 | 54.4
| CHB | 48.5 | 43.4 | 8.1
| CHD | 62.4 | 30.3 | 7.3
| GIH | 47.5 | 39.6 | 12.9
| LWK | 2.7 | 32.7 | 64.5
| MEX | 56.9 | 37.9 | 5.2
| MKK | 14.7 | 41.7 | 43.6
| TSI | 52.0 | 41.2 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=1E-6
  |OR=1.61
  |ORtxt=[1.330-1.937]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}